Multidrug-resistant Acinetobacter baumannii: Molecular insights, clinical challenges, and therapeutic approaches
- 10 May 2026
- journal article
- review article
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 246, 107544
Abstract
No abstract availableKeywords
Funding Information
- Symbiosis International University
This publication has 83 references indexed in Scilit:
- Simultaneous functional disruption of the iron acquisition system and type VI secretion system results in complete suppression of virulence in Acinetobacter baumanniiMicrobiological Research, 2025
- Targeting the quorum sensing network in Acinetobacter baumannii: A dual target structure-based approach for the development of novel antimicrobialsComputers in Biology and Medicine, 2025
- Use of nanotechnology-based nanomaterial as a substitute for antibiotics in monogastric animalsHeliyon, 2024
- Co-production of metallo-β-lactamase and OXA-type β-lactamases in carbapenem-resistant Acinetobacter baumannii clinical isolates in North East IndiaWorld Journal of Microbiology and Biotechnology, 2024
- Antibiotic resistance and tolerance: What can drug delivery do against this global threat?Drug Delivery and Translational Research, 2024
- Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategiesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2023
- Anti-capsular activity of CuO nanoparticles against Acinetobacter baumannii produce efflux pumpMicrobial Pathogenesis, 2023
- PhageScore-based analysis of Acinetobacter baumannii infecting phages antibiotic interaction in liquid mediumArchives of Microbiology, 2022
- Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter baumanniiJournal of Hospital Infection, 2020
- Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond?Drug Resistance Updates, 2012